HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 604 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $809,830,000 | +12.5% | 7,000,000 | 0.0% | 12.63% | +29.3% |
Q2 2023 | $719,950,000 | -5.8% | 7,000,000 | 0.0% | 9.77% | -13.8% |
Q1 2023 | $763,980,000 | -4.1% | 7,000,000 | 0.0% | 11.33% | -4.9% |
Q4 2022 | $796,600,000 | +151.1% | 7,000,000 | +36.6% | 11.90% | +103.2% |
Q3 2022 | $317,186,000 | -20.5% | 5,125,000 | +2.5% | 5.86% | -25.6% |
Q2 2022 | $398,800,000 | -41.7% | 5,000,000 | -23.1% | 7.88% | -36.9% |
Q1 2022 | $683,865,000 | -31.7% | 6,500,000 | -30.1% | 12.48% | -26.8% |
Q4 2021 | $1,001,629,000 | +1.6% | 9,295,000 | +3.3% | 17.05% | +10.1% |
Q3 2021 | $985,860,000 | +17.0% | 9,000,000 | 0.0% | 15.49% | +5.6% |
Q2 2021 | $842,760,000 | +1.7% | 9,000,000 | 0.0% | 14.66% | +2.5% |
Q1 2021 | $828,360,000 | +25.8% | 9,000,000 | 0.0% | 14.31% | +26.2% |
Q4 2020 | $658,350,000 | +10.8% | 9,000,000 | +17.6% | 11.34% | +34.3% |
Q3 2020 | $594,252,000 | +78.2% | 7,650,000 | +27.5% | 8.44% | +28.1% |
Q2 2020 | $333,480,000 | +146.1% | 6,000,000 | +31.1% | 6.59% | +44.1% |
Q1 2020 | $135,512,000 | -6.4% | 4,575,000 | +14.4% | 4.57% | +7.6% |
Q4 2019 | $144,800,000 | +32.9% | 4,000,000 | 0.0% | 4.25% | -6.4% |
Q3 2019 | $108,920,000 | +13.2% | 4,000,000 | 0.0% | 4.54% | +36.6% |
Q2 2019 | $96,240,000 | – | 4,000,000 | – | 3.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |